WELCOME TO THE
COST ACTION CA20122 Harmonisation
Harmonizing clinical care and research on adrenal tumors in European countries
Final Masterclass and Final Conference of the CA20122: Joint 24th ENS@T Scientific Meeting and 4th Harmonisation Meeting
We would like to sincerely thank you for your participation in the Final Masterclass and Final Conference of the CA20122: Joint 24th ENS@T Scientific Meeting and 4th H@rmonisation Meeting. Your presence and contributions made the event truly inspiring and successful.
You will receive Certificates of Attendance and link to photos by email so please check your spam folders as well.
In addition, the Abstract Book has been uploaded online and is accessible on our website here.
We hope that the knowledge exchanged during the meeting will support your future work and collaborations.
4th call for the Short Term Scientific Missions (STSM)
The 4th call for the Short Term Scientific Missions (STSM) applications for Missions occurring until 31/08/2025 is open. Deadline for applications to be submitted is 01/02/2025.
Latest news
Connecting Endocrinology Across the Life Course
ESE Summer School 2025
12th ESE Young Endocrinologists & Scientists (EYES) Meeting
Join Harmonisation
Harmonis@tion is an open, interdisciplinary and growing network welcoming clinicians, scientists and relevant stakeholders to contribute to the activities of the action.
COST
COST is an EU funding programme that enables researchers to set up their interdisciplinary research networks in Europe and beyond. We provide funds for organising conferences, meetings, training schools, short scientific exchanges or other networking activities in a wide range of scientific topics. By creating open spaces where people and ideas can grow, we unlock the full potential of science.
HARMONIS@TION
Harmonis@tion aims to constitute a multidisciplinary network to harmonize clinical care and research on adrenal tumours throughout Europe with a focus on COST Inclusiveness Target Countries. In addition, this collaborative network will establish a modern framework to develop a new generation of real-time and real-life randomized clinical trials, which will be federated and registry-based.
Action Details
Start of Action: 28/09/2021
End of Action: 27/09/2025
